HOLLAND & KNIGHT LLP

Lobbying for NOVO NORDISK, INC. · Pharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $60,000.00 income · posted Apr 10, 2026

Lobbying activity 2

Budget/Appropriations

Legislation related to obesity treatments; Advocacy for antiobesity medications.

Health Issues

Legislation related to obesity treatments; Advocacy for antiobesity medications.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.